East Setauket, NY, United States of America

John S Kovach

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 292(Granted Patents)


Location History:

  • Wyandotte, MI (US) (1999)
  • New York, NY (US) (2002)
  • East Setauket, NY (US) (2011 - 2022)
  • Pasadena, CA (US) (2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: John S. Kovach: A Pioneer in Pharmaceutical Innovations

Introduction: John S. Kovach is a renowned inventor based in East Setauket, NY, with an impressive portfolio of 26 patents to his name. His work primarily focuses on pharmaceutical compounds, where he has made significant contributions to drug development. His recent innovations demonstrate a commitment to advancing medical science and improving treatment options.

Latest Patents: Among his latest patents is the development of Oxabicycloheptane prodrugs, which presents a novel compound structure aimed at enhancing drug efficacy and safety. This patent reflects Kovach's continuous efforts to innovate within the pharmaceutical realm and showcases his advanced understanding of medicinal chemistry.

Career Highlights: Throughout his career, John S. Kovach has been associated with various influential companies, including Lixte Biotechnology, Inc., where he has contributed to several successful projects focused on drug discovery and development. His extensive experience in the industry positions him as a leader in innovation and product development.

Collaborations: Kovach has collaborated with notable professionals in the field, including Francis Johnson and Robert A. Volkmann. These partnerships have allowed for a synergy of ideas and expertise, resulting in advancements in pharmaceutical technology and increasing the impact of their work on healthcare.

Conclusion: John S. Kovach stands out as a transformative figure in the pharmaceutical industry. With a growing number of patents and collaborations, his work continues to push the boundaries of drug innovation, ultimately aiming to improve patient outcomes and advance the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…